Medications for Atopic Dermatitis

11 results
  • cibinqo - abrocitinib tablet, film coated

    (Abrocitinib)
    U.S. Pharmaceuticals
    CIBINQO treats moderate-to-severe atopic dermatitis in adults and pediatric patients 12 and older whose disease is not adequately controlled by other systemic therapies, including biologics, or when those therapies are inadvisable. Not recommended with other JAK inhibitors, biologic immunomodulators, or immunosuppressants.
  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    DUPIXENT treats moderate-to-severe atopic dermatitis (6 months+), asthma (6 years+), chronic rhinosinusitis with nasal polyps (12 years+), eosinophilic esophagitis (1 year+), prurigo nodularis, COPD, chronic spontaneous urticaria (12 years+), bullous pemphigoid, and allergic fungal rhinosinusitis in eligible adult and pediatric patients.
  • ebglyss - lebrikizumab - lbkz injection, solution

    (Lebrikizumab-Lbkz)
    Eli Lilly And Company
    Ebglyss treats moderate-to-severe atopic dermatitis in adults and patients 12 years and older weighing at least 40 kg whose disease is not adequately controlled with topical therapies. Can be used with or without topical corticosteroids.
  • nemluvio - nemolizumab - ilto injection, powder, lyophilized, for solution

    (Nemolizumab-Ilto)
    Galderma Laboratories, L.P.
    Nemluvio treats adults with prurigo nodularis, and adults and patients 12 and older with moderate-to-severe atopic dermatitis combined with topical corticosteroids and/or calcineurin inhibitors when topical prescription therapies are inadequate.
  • opzelura - ruxolitinib cream

    (Ruxolitinib)
    Incyte Corporation
    Opzelura treats mild to moderate atopic dermatitis in adults and children 2+ years not adequately controlled by topical therapies, and nonsegmental vitiligo in adults and adolescents 12+ years. Not recommended with biologics, other JAK inhibitors, or potent immunosuppressants.
  • purified cortrophin gel - repository corticotropin injection

    (Repository Corticotropin)
    Ani Pharmaceuticals, Inc.
    Purified Cortrophin Gel treats rheumatic disorders (psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis), collagen diseases (lupus, polymyositis), severe skin conditions, allergic states, inflammatory eye diseases, sarcoidosis, nephrotic syndrome, and acute multiple sclerosis exacerbations.
  • rayos

    (Prednisone)
    Horizon Therapeutics Usa, Inc.
    Rayos (prednisone) treats a wide range of inflammatory and autoimmune conditions including allergic reactions, skin diseases, rheumatologic disorders, respiratory conditions, hematologic diseases, organ transplant rejection, and certain cancers in adults and children.
  • rinvoq - upadacitinib tablet, extended release

    (Upadacitinib)
    Abbvie Inc.
    RINVOQ is a JAK inhibitor indicated for adults and some pediatric patients with rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis, and giant cell arteritis, generally after inadequate response to TNF blockers.
  • vtama - tapinarof cream

    (Tapinarof)
    Organon Llc
    VTAMA cream treats plaque psoriasis in adults and atopic dermatitis in adults and pediatric patients 2 years and older.